|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,338.00 GBX | -0.34% |
|
+1.65% | +9.66% |
| 01-21 | HSBC raises Haleon; Goldman Sachs cuts Admiral | AN |
| 01-05 | Johnson Matthey Rating, Price Target Raised as Berenberg Notes Precious Metal Proxies Correlation | MT |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.22 | 4.48 | 4.35 | 3.41 | 3.83 | |||||
Return on Total Capital | 7.66 | 8.32 | 7.53 | 5.63 | 6.08 | |||||
Return On Equity % | 7.44 | 4.53 | 10.6 | 4.39 | 15.96 | |||||
Return on Common Equity | 7.44 | 4.53 | 10.6 | 4.39 | 15.96 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 6.5 | 6.47 | 6.71 | 6.99 | 7.69 | |||||
SG&A Margin | 3.18 | 3.1 | 3.52 | 4.03 | 4.37 | |||||
EBITDA Margin % | 4.24 | 4.12 | 4.15 | 3.9 | 4.39 | |||||
EBITA Margin % | 3.32 | 3.26 | 3.23 | 2.86 | 3.32 | |||||
EBIT Margin % | 3.25 | 3.22 | 3.19 | 2.84 | 3.29 | |||||
Income From Continuing Operations Margin % | 1.31 | 0.72 | 1.77 | 0.84 | 3.2 | |||||
Net Income Margin % | 1.31 | -0.63 | 1.85 | 0.84 | 3.2 | |||||
Net Avail. For Common Margin % | 1.31 | 0.72 | 1.77 | 0.84 | 3.2 | |||||
Normalized Net Income Margin | 1.67 | 1.77 | 1.74 | 1.36 | 1.78 | |||||
Levered Free Cash Flow Margin | 2.6 | -1.02 | 0.55 | 2.04 | 1.96 | |||||
Unlevered Free Cash Flow Margin | 3.2 | -0.7 | 0.92 | 2.68 | 2.66 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 2.08 | 2.22 | 2.18 | 1.92 | 1.86 | |||||
Fixed Assets Turnover | 10.49 | 11.46 | 11.14 | 8.99 | 7.94 | |||||
Receivables Turnover (Average Receivables) | 9.91 | 9.85 | 10.39 | 10.61 | 11.54 | |||||
Inventory Turnover (Average Inventory) | 7.89 | 8.91 | 8.57 | 8.2 | 9.7 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.35 | 1.33 | 1.51 | 1.45 | 1.42 | |||||
Quick Ratio | 0.81 | 0.68 | 0.85 | 0.87 | 0.96 | |||||
Operating Cash Flow to Current Liabilities | 0.21 | 0.19 | 0.1 | 0.23 | 0.15 | |||||
Days Sales Outstanding (Average Receivables) | 36.82 | 37.06 | 35.14 | 34.51 | 31.63 | |||||
Days Outstanding Inventory (Average Inventory) | 46.28 | 40.95 | 42.59 | 44.63 | 37.63 | |||||
Average Days Payable Outstanding | 20.96 | 21.68 | 20.53 | 23.74 | 22.81 | |||||
Cash Conversion Cycle (Average Days) | 62.14 | 56.33 | 57.2 | 55.4 | 46.44 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 51.25 | 51.33 | 66.29 | 63.15 | 74.64 | |||||
Total Debt / Total Capital | 33.88 | 33.92 | 39.86 | 38.71 | 42.74 | |||||
LT Debt/Equity | 48.53 | 38.55 | 59.31 | 57.69 | 58.82 | |||||
Long-Term Debt / Total Capital | 32.09 | 25.47 | 35.67 | 35.36 | 33.68 | |||||
Total Liabilities / Total Assets | 65.33 | 63.38 | 63.88 | 62.44 | 62.95 | |||||
EBIT / Interest Expense | 3.4 | 6.29 | 5.3 | 2.77 | 2.98 | |||||
EBITDA / Interest Expense | 4.52 | 8.22 | 7.03 | 3.87 | 4.05 | |||||
(EBITDA - Capex) / Interest Expense | 2.49 | 3.85 | 4.22 | 1.59 | 1.6 | |||||
Total Debt / EBITDA | 2.03 | 1.86 | 2.66 | 2.94 | 3.28 | |||||
Net Debt / EBITDA | 1.17 | 1.28 | 1.63 | 1.88 | 1.54 | |||||
Total Debt / (EBITDA - Capex) | 3.68 | 3.97 | 4.43 | 7.16 | 8.28 | |||||
Net Debt / (EBITDA - Capex) | 2.13 | 2.72 | 2.72 | 4.58 | 3.87 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 7.52 | 3.82 | -6.81 | -14 | -9.1 | |||||
Gross Profit, 1 Yr. Growth % | 1.49 | 8.7 | -3.38 | -10.38 | 0 | |||||
EBITDA, 1 Yr. Growth % | -2.92 | 4.27 | -5.93 | -19.06 | 2.2 | |||||
EBITA, 1 Yr. Growth % | -4.41 | 6.95 | -7.49 | -23.86 | 5.72 | |||||
EBIT, 1 Yr. Growth % | -4.32 | 7.72 | -7.2 | -23.48 | 5.21 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -19.61 | -40.21 | 127.59 | -59.09 | 245.37 | |||||
Net Income, 1 Yr. Growth % | -19.61 | -149.27 | -373.27 | -60.87 | 245.37 | |||||
Normalized Net Income, 1 Yr. Growth % | -6.25 | 16.71 | -8.59 | -32.53 | 18.57 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -19.47 | -39.85 | 137.15 | -59.4 | 262.26 | |||||
Accounts Receivable, 1 Yr. Growth % | 26.02 | -15.43 | -7.18 | -25 | -5.11 | |||||
Inventory, 1 Yr. Growth % | -4.63 | -14.61 | 9.88 | -28.85 | -16.52 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 0.47 | -13.28 | 6.31 | 6.88 | -0.81 | |||||
Total Assets, 1 Yr. Growth % | 5.2 | -13.92 | 5.45 | -9.86 | -2.24 | |||||
Tangible Book Value, 1 Yr. Growth % | -3.27 | -2.84 | 4.42 | -8.62 | -3.53 | |||||
Common Equity, 1 Yr. Growth % | -4.92 | -9.09 | 4.01 | -6.26 | -3.57 | |||||
Cash From Operations, 1 Yr. Growth % | 28.6 | -21.33 | -51.9 | 103.44 | -35.64 | |||||
Capital Expenditures, 1 Yr. Growth % | -8.43 | 17.76 | -29.33 | 18.97 | 4.65 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -875.3 | -142.1 | -149.92 | 219.54 | -12.33 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 658.79 | -123.21 | -222.51 | 149.14 | -9.92 | |||||
Dividend Per Share, 1 Yr. Growth % | 25.84 | 10 | 0 | 0 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 20.77 | 4.85 | -1.64 | -10.48 | -11.58 | |||||
Gross Profit, 2 Yr. CAGR % | 0.15 | 1.63 | 2.48 | -6.94 | -5.33 | |||||
EBITDA, 2 Yr. CAGR % | -3.5 | -1.77 | -1.11 | -12.74 | -9.05 | |||||
EBITA, 2 Yr. CAGR % | -4.57 | -1.95 | -0.72 | -16.07 | -10.28 | |||||
EBIT, 2 Yr. CAGR % | -4.31 | -1.61 | -0.21 | -15.73 | -10.28 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -29.55 | -32.55 | 16.65 | -3.51 | 18.86 | |||||
Net Income, 2 Yr. CAGR % | -29.55 | -37.07 | 16.03 | 3.41 | 16.25 | |||||
Normalized Net Income, 2 Yr. CAGR % | -9.34 | 0.67 | 3.29 | -21.47 | -10.56 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -29.59 | -32.3 | 19.43 | -1.88 | 21.27 | |||||
Accounts Receivable, 2 Yr. CAGR % | 18.67 | 3.24 | -11.4 | -16.56 | -15.64 | |||||
Inventory, 2 Yr. CAGR % | 17.41 | -9.76 | -3.14 | -11.58 | -22.93 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 8.56 | -6.66 | -3.98 | 6.6 | 2.96 | |||||
Total Assets, 2 Yr. CAGR % | 14.1 | -4.84 | -4.73 | -2.51 | -6.13 | |||||
Tangible Book Value, 2 Yr. CAGR % | 2.54 | -3.06 | 0.72 | -2.32 | -6.11 | |||||
Common Equity, 2 Yr. CAGR % | 1.41 | -7.03 | -2.76 | -1.26 | -4.93 | |||||
Cash From Operations, 2 Yr. CAGR % | 51.74 | 0.58 | -38.48 | -1.08 | 14.42 | |||||
Capital Expenditures, 2 Yr. CAGR % | 18.91 | 3.84 | -8.77 | -8.31 | 11.58 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 97.95 | 75.86 | -53.98 | 26.3 | 67.38 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 263.97 | 29.85 | -46.38 | 74.7 | 49.81 | |||||
Dividend Per Share, 2 Yr. CAGR % | -9.52 | 17.66 | 4.88 | 0 | 0 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 15.12 | 14.25 | 0.81 | -5.94 | -10.02 | |||||
Gross Profit, 3 Yr. CAGR % | 3.92 | 0.68 | -0.07 | -2 | -4.68 | |||||
EBITDA, 3 Yr. CAGR % | -0.1 | -2.54 | -3.27 | -7.5 | -8.02 | |||||
EBITA, 3 Yr. CAGR % | -0.19 | -2.88 | -3.95 | -9.12 | -9.36 | |||||
EBIT, 3 Yr. CAGR % | 0.33 | -2.52 | -3.63 | -8.66 | -9.26 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -11.72 | -34.51 | 1.16 | -17.74 | 47.6 | |||||
Net Income, 3 Yr. CAGR % | -11.72 | -37.46 | 2.67 | -19.24 | 54.57 | |||||
Normalized Net Income, 3 Yr. CAGR % | -3.47 | -3.87 | -2.52 | -10.38 | -9.91 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -11.79 | -34.41 | 2.82 | -16.65 | 51.65 | |||||
Accounts Receivable, 3 Yr. CAGR % | 17.53 | 6 | -0.36 | -16.19 | -12.91 | |||||
Inventory, 3 Yr. CAGR % | 25.21 | 5.58 | -3.64 | -12.6 | -13.26 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 9.05 | 0.73 | -2.52 | -0.49 | 4.07 | |||||
Total Assets, 3 Yr. CAGR % | 15.09 | 3.87 | -1.53 | -6.47 | -2.42 | |||||
Tangible Book Value, 3 Yr. CAGR % | 5.87 | 0.71 | -0.63 | -2.5 | -2.73 | |||||
Common Equity, 3 Yr. CAGR % | 4.12 | -2.22 | -3.48 | -3.94 | -2.03 | |||||
Cash From Operations, 3 Yr. CAGR % | 25.83 | 21.9 | -21.34 | -8.35 | -14.29 | |||||
Capital Expenditures, 3 Yr. CAGR % | 24.64 | 18.53 | -8.66 | -0.33 | -4.18 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 26.88 | 16.05 | 15.87 | -12.21 | 11.83 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 28.47 | 43.32 | 27.83 | -10.52 | 40.09 | |||||
Dividend Per Share, 3 Yr. CAGR % | -4.35 | -3.43 | 11.45 | 3.23 | 0 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 7.9 | 5.9 | 7.77 | 3.63 | -4.34 | |||||
Gross Profit, 5 Yr. CAGR % | 5.85 | 3.77 | 1.99 | -2.44 | -2.21 | |||||
EBITDA, 5 Yr. CAGR % | 3 | 0.24 | -1.45 | -6.81 | -5.63 | |||||
EBITA, 5 Yr. CAGR % | 3.17 | 0.39 | -1.62 | -8.46 | -6.54 | |||||
EBIT, 5 Yr. CAGR % | 3.67 | 0.92 | -1.13 | -8.11 | -6.35 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -8.84 | -21.33 | -2.39 | -23.53 | 7.9 | |||||
Net Income, 5 Yr. CAGR % | -9.25 | -23.52 | -1.52 | -23.53 | 7.9 | |||||
Normalized Net Income, 5 Yr. CAGR % | 0.4 | -0.42 | -2.33 | -11.34 | -5.82 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -8.5 | -21.32 | -1.52 | -22.94 | 9.84 | |||||
Accounts Receivable, 5 Yr. CAGR % | 17.37 | 9.09 | 4.97 | -3.68 | -6.78 | |||||
Inventory, 5 Yr. CAGR % | 22.65 | 14.94 | 12.99 | -1.65 | -11.87 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 6.64 | 1.02 | 3.64 | 3.04 | -0.36 | |||||
Total Assets, 5 Yr. CAGR % | 13.8 | 7.39 | 6.71 | 1.27 | -3.39 | |||||
Tangible Book Value, 5 Yr. CAGR % | 11.12 | 5.27 | 3.78 | -0.51 | -2.86 | |||||
Common Equity, 5 Yr. CAGR % | 7.7 | 1.76 | 1.31 | -1.84 | -4.06 | |||||
Cash From Operations, 5 Yr. CAGR % | -2.36 | 2.96 | -5.49 | 12.13 | -8.62 | |||||
Capital Expenditures, 5 Yr. CAGR % | 9.74 | 13.04 | 10.01 | 6.96 | -1.05 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -9.43 | 20.62 | -16.34 | 20.23 | 34.24 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -6.18 | 6.05 | -10.21 | 55.48 | 36.21 | |||||
Dividend Per Share, 5 Yr. CAGR % | -0.42 | 0.53 | -0.76 | -2.07 | 6.72 |
- Stock Market
- Equities
- JMAT Stock
- Financials Johnson Matthey Plc
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















